Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19.

Document Type

Article

Publication Date

9-6-2021

Publication Title

Nature biotechnology

Keywords

washington; rention; system; california; santa monica; isb; seattle; swedish; sjci; covid-19

Abstract

A better understanding of the metabolic alterations in immune cells during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may elucidate the wide diversity of clinical symptoms experienced by individuals with coronavirus disease 2019 (COVID-19). Here, we report the metabolic changes associated with the peripheral immune response of 198 individuals with COVID-19 through an integrated analysis of plasma metabolite and protein levels as well as single-cell multiomics analyses from serial blood draws collected during the first week after clinical diagnosis. We document the emergence of rare but metabolically dominant T cell subpopulations and find that increasing disease severity correlates with a bifurcation of monocytes into two metabolically distinct subsets. This integrated analysis reveals a robust interplay between plasma metabolites and cell-type-specific metabolic reprogramming networks that is associated with disease severity and could predict survival.

Clinical Institute

Cancer

Department

Infectious Diseases

Link to Full Text

PSJH Full Text

Share

COinS